Events in North America

Citrix NetScaler ADC and NetScaler Gateway contain an improper input validation vulnerability that could allow an unauthenticated attacker to execute arbitrary commands. CISA guidance directs stakeholders to apply vendor mitigations and follow BOD 26-04 or discontinue use if mitigations are unavailable.

A remote file inclusion vulnerability in WordPress Core could allow an unauthenticated attacker to cause page-template resolution to include a readable local .php file outside active theme directories, potentially leading to remote code execution. The source requires stakeholders to apply vendor mitigations and follow CISA BOD 26-04 and forensics triage guidance, or discontinue use if mitigations are unavailable.

CISA reports a heap-based buffer overflow in F5 BIG-IP APM that can occur when an access policy and an OAuth profile are configured on a virtual server and could allow unauthenticated remote code execution. The advisory directs stakeholders to apply vendor mitigations and follow CISA’s BOD 26-04 patching and forensics triage guidance.

Class II FDA drug recall: ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7504-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7504-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India. Additional details were not included in the source data received by Planet Briefing.

A memory-buffer vulnerability in Citrix NetScaler ADC and NetScaler Gateway could allow remote code execution or denial of service. CISA advises applying vendor mitigations, following BOD 26-04 guidance, assessing internet exposure, and following forensics triage requirements.

Mikrotik RouterOS contains an improper enforcement of behavioral workflow vulnerability that can allow an unauthenticated client to open a session channel and send an exec request and can be chained to exploit CVE-2026-86060. CISA requires applying vendor mitigations and following BOD 26-04 guidance, including evaluating internet exposure or discontinuing use if mitigations are unavailable.

CISA reports a path traversal vulnerability in Check Point Security Management Server, Multi-Domain Security Management Server, Log Server, Multi-Domain Log Server, and SmartEvent that allows an unauthenticated attacker to upload and execute arbitrary scripts. CISA requires applying vendor mitigations and following BOD 26-04 and forensics triage guidance or discontinuing the product if mitigations are unavailable.

Class II FDA drug recall: PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2461-1. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only, packaged in a) 1 mL Multi-Dose Vial (NDC 0517-0031-01), and b) 25x1 mL Multi-Dose Vials (NDC 0517-0031-25) Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3583-01. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only, American Regent, Inc., Shirley, NY 11967. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, Single Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-00. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by: Zydus Lifesciences Limited, Ahmedabad, India; Distributed by: Amneal Pharmaceuticals LC, Bridgewater, NY 08807. NDC: 70121-2453-1. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag Net Wt, RX ONLY "FOR Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesana, Gujarat, 382715, India, (CAS NO. 171599-83-0) NDC 85702-001-05. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL), Distributed by: The Mentholatum Company, Orchard Park, NY 14127, Made in Vietnam, UPC 310742011012, NDC 10742-8158-1. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oil, 2 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-5, UPC 8 50041 64003 7. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL (50 mg/mL), For Intravenous Infusion After Dilution, Single-Dose Vial, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; Marketed by: Regeneron Pharmaceuticals, Inc. (Tarrytown, NY 10591), NDC 61755-008-01. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India. Additional details were not included in the source data received by Planet Briefing.

Class II FDA drug recall: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50. Additional details were not included in the source data received by Planet Briefing.